Logo image
Se connecter
Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma
Acte de colloque

Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma

Lionel Perrier, Anne Lefranc, Philippe Quittet, Philippe Moreau, Carole Siani, Hervé Ghesquières, Fabrice Jardin, Bertrand Favier, Norbert Ifrah, Séverine Lissandre, …
16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, Etats-Unis, 25 mai 2011 (Baltimore, United States, 25/05/2011–25/05/2011)

Résumé

Cost-effectiveness Pegfilgrastim Filgrastim I - Health, Education, and Welfare/I.I1 - Health I - Health, Education, and Welfare/I.I1 - Health/I.I1.I11 - Analysis of Health Care Markets I - Health, Education, and Welfare/I.I1 - Health/I.I1.I18 - Government Policy • Regulation • Public Health

Fichiers et liens (1)

url
Find in HALAfficher

Indicateurs

1 Consultations de la notice

Détails

Logo image